Studies

A clinical research study is enrolling adults with narcolepsy to evaluate an investigational medication.

A clinical study is evaluating an oral investigational medication for adults with major depressive disorder.

This study evaluates an investigational treatment option for Restless Legs Syndrome (RLS) based on a wearable device therapy.

A clinical study for adults with elevated lipoprotein(a) (Lp[a]) to evaluate whether a study drug can reduce the risk of a first major cardiovascular event.

A clinical study for adults with autoimmune hepatitis that has not responded or are intolerant to current standard of care available.

A clinical study for adults with newly diagnosed or relapsed ANCA-associated vasculitis, including granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA). If you have GPA or MPA, you may be eligible for this study, which is evaluating a study drug.

A clinical study for adults with uncontrolled gout. If you have gout that is not under control, you may be eligible for this study, which is evaluating the safety and efficacy of the study drug administered as a subcutaneous injection compared to an IV infusion.

A clinical study for adults with primary membranous nephropathy to understand how a study drug reduces symptoms and helps preserve kidney function.

If you or a loved one has leukemia or lymphoma, learn more about this opportunity to participate in a clinical study evaluating a one-time investigational gene therapy that may help your immune system fight cancer more effectively.

A study for families navigating pediatric generalized myasthenia gravis

For those living with either focal-onset seizures (FOS) or primary generalized tonic-clonic seizures (PGTCS), you may be eligible for a clinical trial that may help reduce the frequency of seizures.

A clinical study for adults with refractory (treatment-resistant) rheumatoid arthritis (RA). If you have refractory rheumatoid arthritis, you may be eligible for this study, which is evaluating if a study drug, blinatumomab, for rheumatoid arthritis.